According to the FDA’s legal definition, a drug is anything that “diagnoses, cures, mitigates, treats, or prevents a disease.” The problem with this definition is that there are numerous substances, as readily available and benign as found on our spice racks, which have been proven by countless millennia of human experience to mitigate, prevent and in some cases cure disease, and which cannot be called drugs according to the FDA. How can this be? Well, the FDA has assumed for itself Godlike power, requiring that its official approval be obtained before any substance can legally be used in the prevention and treatment of disease.
The FDA’s legal-regulatory control therefore is totalitarian and Napoleonic in construct; what it does not explicitly permit as a medicine is implicitly forbidden. Historically the FDA has required new drugs undergo expensive and elaborate multi-phased clinical trials, which are out of the grasp of any ordinary interest who might want to demonstrate the efficacy of a non-patentable (and therefore unprofitable) herb, food or spice. The average out-of-pocket cost for obtaining a new drug approval is 2.6 billion dollars, and therefore an investor putting capital into bringing to market a substance that does not lend itself to market exclusivity and therefore:
Oncology nurse walks away from a career right before retirement after discovering doctors and government putting proven cures for diseases down the “1984” memory hole. After 17 years as an oncology nurse, Valerie Warwick took a huge risk and walked away from a lucrative income because she could not be a part of the conventional cancer industry anymore. In our interview, Valerie shares insider information about the industry as well as vital resources and therapies that every cancer patient should consider.